We founded Alector with one guiding principle. Do everything using a hypothesis-driven approach. 

Our hypothesis is that the immune system plays a critical part in the development of all neurodegenerative diseases and cancer.

Our action is to employ a comprehensive approach, leveraging the immune system, to cure these complex disorders.

We are currently working on novel, first-in-class drugs born out of this hypothesis. We believe this unifying theme of controlling the immune system has the potential to cure both neurodegeneration and many forms of cancer.